Cargando…

Rethinking the therapeutic misconception: social justice, patient advocacy, and cancer clinical trial recruitment in the US safety net

BACKGROUND: Approximately 20% of adult cancer patients are eligible to participate in a clinical trial, but only 2.5-9% do so. Accrual is even less for minority and medically underserved populations. As a result, critical life-saving treatments and quality of life services developed from research st...

Descripción completa

Detalles Bibliográficos
Autor principal: Burke, Nancy J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4177718/
https://www.ncbi.nlm.nih.gov/pubmed/25240404
http://dx.doi.org/10.1186/1472-6939-15-68